07.02.2013
- Swiss biotech group Basilea said its chief financial officer was leaving the company just two months after the departure of the firm's founder and chief executive. Joachim Blatter...
14.06.2011
- Biotech deals in the $1 billion to $5 billion range are likely to be a sweet spot for drug companies looking to bolster their pipelines through M&A in an increasingly tough...
